Vanguard Fiduciary Trust’s eXoZymes Inc EXOZ Stock Holding History

Vanguard Fiduciary Trust’s Portfolio EXOZ Stock Details EXOZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.5K	Hold	9,426	–	–	﹤0.01%	3778
2026 Q1	$70.7K	Buy	+9,426	New	+$86.2K	﹤0.01%	3771

Other funds holding EXOZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DKCM

Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Fiduciary Trust's EXOZ Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its eXoZymes Inc (EXOZ) position steady in Q2 2026 at 9,426 shares worth $79.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

Vanguard Fiduciary Trust first reported a position in EXOZ in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold EXOZ as of Q2 2026.

Vanguard Fiduciary Trust held 9,426 shares of eXoZymes Inc worth $79.5K as of Q2 2026.
Vanguard Fiduciary Trust left its eXoZymes Inc share count unchanged in Q2 2026.
eXoZymes Inc made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3778 holding.
Vanguard Fiduciary Trust first reported a position in eXoZymes Inc in Q1 2026 and has held it in 2 quarters since.
10 funds tracked by Wall St. Rank held eXoZymes Inc as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.